Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Change in Account Payables (2020 - 2025)

Celularity (CELU) has disclosed Change in Account Payables for 6 consecutive years, with $187000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Change in Account Payables fell 89.06% to $187000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $9.2 million, a 201.73% increase, with the full-year FY2024 number at $9.2 million, up 8.73% from a year prior.
  • Change in Account Payables was $187000.0 for Q3 2025 at Celularity, down from $1.1 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $7.9 million in Q4 2024 to a low of -$3.2 million in Q4 2022.
  • A 5-year average of $1.0 million and a median of $775000.0 in 2024 define the central range for Change in Account Payables.
  • Peak YoY movement for Change in Account Payables: skyrocketed 2033.77% in 2021, then crashed 297.5% in 2022.
  • Celularity's Change in Account Payables stood at $1.6 million in 2021, then plummeted by 297.5% to -$3.2 million in 2022, then surged by 153.71% to $1.7 million in 2023, then surged by 354.79% to $7.9 million in 2024, then crashed by 97.64% to $187000.0 in 2025.
  • Per Business Quant, the three most recent readings for CELU's Change in Account Payables are $187000.0 (Q3 2025), $1.1 million (Q2 2025), and $17000.0 (Q1 2025).